In this issue:
Pirfenidone for IPF
Nintedanib for IPF
Acetylcysteine for IPF
Long-term safety of pirfenidone in IPF
IPF in US beneficiaries aged ≥65 years
Diagnostic yield of transbronchial cryobiopsy in ILD
Predicting relapse after infliximab discontinuation in severe sarcoidosis
Clinicoradiological staging system for pulmonary sarcoidosis
Serum VEGF-D as biomarker of LAM severity and response
Please login below to download this issue (PDF)